4527 — Rohto Pharmaceutical Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapNeutral

Annual cashflow statement for Rohto Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	27,953	34,290	41,518	42,331	46,821
Depreciation
Amortisation
Non-Cash Items	1,792	1,112	-563	-2,643	-3,174
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-10,167	-12,278	-15,374	-15,697	-13,094
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	27,251	30,925	34,268	37,134	47,930
Capital Expenditures	-11,328	-9,908	-8,912	-10,561	-26,251
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-5,078	-3,268	-7,405	-78,609	-3,529
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-16,406	-13,176	-16,317	-89,170	-29,780
Financing Cash Flow Items	-698	-1,641	-7,086	15,484	-4,459
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	3,470	-16,199	-13,784	35,319	-11,845
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	18,650	6,786	8,870	-13,343	9,630